This information was originally presented on September 14, 2012, at the NCCN 7^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

Vaccination is an important strategy for preventing infections in patients with hematologic malignancies. Hematopoietic cell transplant (HCT) recipients have diminished immunity against vaccine-preventable diseases after transplantation.